Artificial intelligence has reached a new milestone in the long-running debate over machine creativity, according to the largest study ever conducted comparing human creativity with that of generative AI systems.
Here, Mike Brown, Director of Industry Collaboration & Strategic Partnerships at the University of Salford, details the recent developments in electric vehicle innovation and charging infrastructure.
In the face of the current health emergency, Microsoft Azure and Office 365 are inevitably having to scale resources. Andy Powell, Cloud CTO at Jisc, shares advice for dealing with capacity issues.
Innovative technologies have the power to entirely transform the NHS, mitigating the workforce challenges that it faces and transforming the patient experience, whilst improving outcomes, Justin Hall, Vice President and General Manager at iRhythm, discusses here.
Dr. Josef Penninger led an international team from the University of British Columbia to pioneer a trial drug that could stop infection in the early stages of COVID-19.
Jay Sibbitts, Prof Dr Stefan H. Bossmann and Prof Dr Christopher T. Culbertson, from Kansas State University, Department of Chemistry in the U.S., underline microfluidic detection of intracellular nitric oxide levels.
Here, Dr Carlos Ziebert, Karlsruhe Institute of Technology, discusses progress in battery research through safety and ageing studies using calorimeters.
Kris Bachus and Julie Metta from the HIVA Research Institute of KU Leuven, Belgium, present Pop-Machina, a Horizon 2020 Innovation project that promotes circular maker communities in urban areas.
